Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EnteroMedics' Weighty Financing for Obesity

This article was originally published in Start Up

Executive Summary

EnteroMedics recently earned the distinction of closing the second-largest financing for a private medical device company in 2006. Its success was undoubtedly due to the company's attractive position at the junction of two of the device industry's hottest markets: obesity and neuromodulation. EnteroMedics is developing an implantable impulse generator that it hopes will address multiple mechanisms in obesity.

Related Content

Device IPO Class of 2007 Making News, Some Returns
Device Financing in 2006: Closing the Gap with Biopharma
New Data Highlights Benefits, Risks of Obesity Surgery
US Markets for Neurostimulation Products
VCs Turn to Late-Stage Devices
Clinical Update (09/2006)
Neurostimulation's Billion-Dollar Markets
Picking up the Pacing in Obesity: Medtronic acquires Transneuronix
Obesity: Super-Sized Medical Device Market
IntraPace Inc.


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts